pharmacodynamic and pharmacokinetic properties of proton pump inhibitors and their clinical impact – focus on rabeprazole
Comparative pharmacodynamic review of rabeprazole – focus on day 1 data
Fast acid control and rapid symptom relief for patients with gastro-oesophageal reflux disease – the evidence from proton pump inhibitor studies
Understanding the pharmacodynamic and pharmacokinetic differences between proton pump inhibitors – focus on pKa and metabolism